Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Chemotherapy × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Conditions

Breast Neoplasms 2197 Neoplasms 2005 Lung Neoplasms 1083 Colorectal Neoplasms 1020 Prostatic Neoplasms 884 Carcinoma, Non-Small-Cell Lung 743 Carcinoma, Hepatocellular 663 Stomach Neoplasms 595 Pancreatic Neoplasms 587 Head and Neck Neoplasms 430 Ovarian Neoplasms 425 Colonic Neoplasms 422 Rectal Neoplasms 404 Uterine Cervical Neoplasms 400 Esophageal Neoplasms 341 Brain Neoplasms 329 Neoplasm Metastasis 322 Melanoma 303 Multiple Myeloma 299 Precursor Cell Lymphoblastic Leukemia-Lymphoma 290 Urinary Bladder Neoplasms 284 Leukemia, Myeloid, Acute 272 Lymphoma 267 Hematologic Neoplasms 250 Liver Neoplasms 249 Endometrial Neoplasms 248 Disease 235 Recurrence 219 Glioma 213 Carcinoma, Renal Cell 207

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03701607 2018-10-10

Effect of Chemotherapy on PD-L1 in NSCLC

Shanghai Changzheng Hospital

Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡